Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J Logothetis
Eleni Efstathiou
Fil Manuguid
Peter Kirkpatrick

Showing results (61-70 of 476) with videos related to

Pageof 48
Sort By:
Nature Reviews. Drug Discovery|April 7, 2009
Specificity concerns with antibodies for receptor mappingPeter Kirkpatrick
Cancers|December 19, 2020
Neuroendocrine and Aggressive-Variant Prostate CancerNicholas Spetsieris, Myrto Boukovala, Georgios Patsakis, et al.
Molecular Imaging and Biology|May 12, 2018
Androgen Receptor Signaling in Castration-Resistant Prostate Cancer Alters Hyperpolarized Pyruvate to Lactate Conversion and Lactate Levels In VivoNiki Zacharias, Jaehyuk Lee, Sumankalai Ramachandran, et al.
The Lancet. Oncology|July 31, 2002
Stem-cell origin of metastasis and heterogeneity in solid tumoursShi-Ming Tu, Sue-Hwa Lin, Christopher J Logothetis
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2008
Understanding the biology of bone metastases: key to the effective treatment of prostate cancerChristopher J Logothetis, Nora M Navone, Sue-Hwa Lin
Clinical Nuclear Medicine|November 19, 2020
Prostate Cancer Liver Metastases Presenting as Relatively Photopenic Lesions on 18F-Fluciclovine PET/CTAli Baiomy, Lucia Martiniova, Eleni Efstathiou, et al.
European Urology|June 10, 2019
Clinical and Biological Characterisation of Localised High-risk Prostate Cancer: Results of a Randomised Preoperative Study of a Luteinising Hormone-releasing Hormone Agonist with or Without Abiraterone Acetate plus PrednisoneEleni Efstathiou, John W Davis, Louis Pisters, et al.
Journal of Cell Science & Therapy|August 9, 2021
Application of a Successful Germ Cell Tumor Paradigm to the Challenges of Common Adult Solid CancersShi-Ming Tu, Matthew Campbell, Amishi Shah, et al.
International Braz J Urol : Official Journal of the Brazilian Society of Urology|July 16, 2011
The role of the cell adhesion molecules (integrins/cadherins) in prostate cancerAlexandros Drivalos, Athanasios G Papatsoris, Michael Chrisofos, et al.
Thoracic Cancer|August 18, 2023
Real-world treatment patterns and clinical outcomes after introduction of immune checkpoint inhibitors: Results from a retrospective chart review of patients with advanced/metastatic non-small cell lung cancer in the EU5Alexander Slowley, Kelesitse Phiri, Jasjit K Multani, et al.
Pageof 48

Showing results (61-70 of 476) with videos related to

Sort By:
Pageof 48
Nature Reviews. Drug Discovery|April 7, 2009
Specificity concerns with antibodies for receptor mappingPeter Kirkpatrick
Cancers|December 19, 2020
Neuroendocrine and Aggressive-Variant Prostate CancerNicholas Spetsieris, Myrto Boukovala, Georgios Patsakis, et al.
Molecular Imaging and Biology|May 12, 2018
Androgen Receptor Signaling in Castration-Resistant Prostate Cancer Alters Hyperpolarized Pyruvate to Lactate Conversion and Lactate Levels In VivoNiki Zacharias, Jaehyuk Lee, Sumankalai Ramachandran, et al.
The Lancet. Oncology|July 31, 2002
Stem-cell origin of metastasis and heterogeneity in solid tumoursShi-Ming Tu, Sue-Hwa Lin, Christopher J Logothetis
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2008
Understanding the biology of bone metastases: key to the effective treatment of prostate cancerChristopher J Logothetis, Nora M Navone, Sue-Hwa Lin
Clinical Nuclear Medicine|November 19, 2020
Prostate Cancer Liver Metastases Presenting as Relatively Photopenic Lesions on 18F-Fluciclovine PET/CTAli Baiomy, Lucia Martiniova, Eleni Efstathiou, et al.
European Urology|June 10, 2019
Clinical and Biological Characterisation of Localised High-risk Prostate Cancer: Results of a Randomised Preoperative Study of a Luteinising Hormone-releasing Hormone Agonist with or Without Abiraterone Acetate plus PrednisoneEleni Efstathiou, John W Davis, Louis Pisters, et al.
Journal of Cell Science & Therapy|August 9, 2021
Application of a Successful Germ Cell Tumor Paradigm to the Challenges of Common Adult Solid CancersShi-Ming Tu, Matthew Campbell, Amishi Shah, et al.
International Braz J Urol : Official Journal of the Brazilian Society of Urology|July 16, 2011
The role of the cell adhesion molecules (integrins/cadherins) in prostate cancerAlexandros Drivalos, Athanasios G Papatsoris, Michael Chrisofos, et al.
Thoracic Cancer|August 18, 2023
Real-world treatment patterns and clinical outcomes after introduction of immune checkpoint inhibitors: Results from a retrospective chart review of patients with advanced/metastatic non-small cell lung cancer in the EU5Alexander Slowley, Kelesitse Phiri, Jasjit K Multani, et al.
Pageof 48